🇺🇸 FDA
Patent

US 11925642

Regulation of eIF4E activity for migraine therapy

granted A61KA61K31/05A61K31/167

Quick answer

US patent 11925642 (Regulation of eIF4E activity for migraine therapy) held by The Board of Regents of the University of Texas System expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/05, A61K31/167, A61K31/19, A61K31/343